Adrenomedullin is a useful biomarker for the prognosis of critically ill septic children

Biomark Med. 2014;8(9):1065-72. doi: 10.2217/bmm.14.77.

Abstract

Aim: To measure midregional pro-adrenomedullin (MR-pro-ADM) in critically ill septic patients to determine its prognostic usefulness as compared with other used biomarkers in pediatric intensive care units, C-reactive protein (CRP) and procalcitonin (PCT).

Materials & methods: Prospective observational study conducted on 95 patients.

Results: Mean levels of MR-pro-ADM were significantly higher when patients needed mechanical ventilation (3.2 ± 4.3 vs 1.6 ± 2.4) and inotropes (4.4 ± 5.2 vs 1.3 ± 1.2). Receiver operating characteristic curves of mortality were higher for MR-pro-ADM (cut-off value of 2.2). This marker showed higher positive predictive prognostic value than PCT and CRP (31 vs 21.6% and 15.8%, respectively).

Conclusion: MR-pro-ADM levels are good indicators of disease severity and show better reliability than PCT and CRP for predicting in-hospital mortality.

Keywords: C-reactive protein; adrenomedullin; diagnostic; procalcitonin; sepsis.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenomedullin / blood*
  • Child
  • Child, Preschool
  • Critical Illness
  • Disease-Free Survival
  • Female
  • Hospital Mortality
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Predictive Value of Tests
  • Prospective Studies
  • Sepsis / blood*
  • Sepsis / mortality*
  • Sepsis / therapy
  • Survival Rate

Substances

  • Adrenomedullin